Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21602524rdf:typepubmed:Citationlld:pubmed
pubmed-article:21602524lifeskim:mentionsumls-concept:C0023434lld:lifeskim
pubmed-article:21602524lifeskim:mentionsumls-concept:C0023690lld:lifeskim
pubmed-article:21602524lifeskim:mentionsumls-concept:C2754998lld:lifeskim
pubmed-article:21602524lifeskim:mentionsumls-concept:C1979963lld:lifeskim
pubmed-article:21602524lifeskim:mentionsumls-concept:C2003903lld:lifeskim
pubmed-article:21602524lifeskim:mentionsumls-concept:C1710548lld:lifeskim
pubmed-article:21602524pubmed:issue4lld:pubmed
pubmed-article:21602524pubmed:dateCreated2011-7-29lld:pubmed
pubmed-article:21602524pubmed:abstractTextChronic lymphocytic leukemia (CLL) is characterized by a highly variable clinical course with 2 extreme subsets: indolent, ZAP70(-) and mutated immunoglobulin heavy chain gene (M-CLL); and aggressive, ZAP70(+) and unmutated immunoglobulin heavy chain (UM-CLL). Given the long-term suspicion of antigenic stimulation as a primum movens in the disease, the role of the B-cell receptor has been extensively studied in various experimental settings; albeit scarcely in a comparative dynamic proteomic approach. Here we use a quantitative 2-dimensional fluorescence difference gel electrophoresis technology to compare 48 proteomic profiles of the 2 CLL subsets before and after anti-IgM ligation. Differentially expressed proteins were subsequently identified by mass spectrometry. We show that unstimulated M- and UM-CLL cells display distinct proteomic profiles. Furthermore, anti-IgM stimulation induces a specific proteomic response, more pronounced in the more aggressive CLL. Statistical analyses demonstrate several significant protein variations according to stimulation conditions. Finally, we identify an intermediate form of M-CLL cells, with an indolent profile (ZAP70(-)) but sharing aggressive proteomic profiles alike UM-CLL cells. Collectively, this first quantitative and dynamic proteome analysis of CLL further dissects the complex molecular pathway after B-cell receptor stimulation and depicts distinct proteomic profiles, which could lead to novel molecular stratification of the disease.lld:pubmed
pubmed-article:21602524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21602524pubmed:languageenglld:pubmed
pubmed-article:21602524pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21602524pubmed:citationSubsetAIMlld:pubmed
pubmed-article:21602524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21602524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21602524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21602524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21602524pubmed:statusMEDLINElld:pubmed
pubmed-article:21602524pubmed:monthJullld:pubmed
pubmed-article:21602524pubmed:issn1528-0020lld:pubmed
pubmed-article:21602524pubmed:authorpubmed-author:LeblondVéroni...lld:pubmed
pubmed-article:21602524pubmed:authorpubmed-author:HerbrechtRaou...lld:pubmed
pubmed-article:21602524pubmed:authorpubmed-author:BahramSeiamak...lld:pubmed
pubmed-article:21602524pubmed:authorpubmed-author:GribbenJohn...lld:pubmed
pubmed-article:21602524pubmed:authorpubmed-author:BénéMarie-Chr...lld:pubmed
pubmed-article:21602524pubmed:authorpubmed-author:Merle-BéralHé...lld:pubmed
pubmed-article:21602524pubmed:authorpubmed-author:DaviFrédéricFlld:pubmed
pubmed-article:21602524pubmed:authorpubmed-author:JacobFrédéric...lld:pubmed
pubmed-article:21602524pubmed:authorpubmed-author:VallatLaurent...lld:pubmed
pubmed-article:21602524pubmed:authorpubmed-author:NadaudSophieSlld:pubmed
pubmed-article:21602524pubmed:authorpubmed-author:PionneauCédri...lld:pubmed
pubmed-article:21602524pubmed:authorpubmed-author:PerrotAuroreAlld:pubmed
pubmed-article:21602524pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21602524pubmed:day28lld:pubmed
pubmed-article:21602524pubmed:volume118lld:pubmed
pubmed-article:21602524pubmed:ownerNLMlld:pubmed
pubmed-article:21602524pubmed:authorsCompleteYlld:pubmed
pubmed-article:21602524pubmed:paginatione1-15lld:pubmed
pubmed-article:21602524pubmed:meshHeadingpubmed-meshheading:21602524...lld:pubmed
pubmed-article:21602524pubmed:meshHeadingpubmed-meshheading:21602524...lld:pubmed
pubmed-article:21602524pubmed:meshHeadingpubmed-meshheading:21602524...lld:pubmed
pubmed-article:21602524pubmed:meshHeadingpubmed-meshheading:21602524...lld:pubmed
pubmed-article:21602524pubmed:meshHeadingpubmed-meshheading:21602524...lld:pubmed
pubmed-article:21602524pubmed:meshHeadingpubmed-meshheading:21602524...lld:pubmed
pubmed-article:21602524pubmed:meshHeadingpubmed-meshheading:21602524...lld:pubmed
pubmed-article:21602524pubmed:year2011lld:pubmed
pubmed-article:21602524pubmed:articleTitleA unique proteomic profile on surface IgM ligation in unmutated chronic lymphocytic leukemia.lld:pubmed
pubmed-article:21602524pubmed:affiliationLaboratoire d'Immunogénétique Moléculaire Humaine, Centre de Recherche d'Immunologie et d'Hématologie, Faculté de Médecine, Université de Strasbourg, Strasbourg, France.lld:pubmed
pubmed-article:21602524pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21602524pubmed:publicationTypeCommentlld:pubmed
pubmed-article:21602524pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:21602524lld:pubmed